Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Carbamazepine-associated hepatitis].

S Gillis1, E J Dann

  • 1Dept. of Internal Medicine B, Hadassah-University Hospital, Ein Karem, Jerusalem.

Harefuah
|December 16, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center study.

Annals of hematology·2019
Same author

Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts.

Postgraduate medical journal·2015
Same author

Interleukins: a rose is a rose ….

Immunology today·2014
Same author

T-cell growth factors: interleukin 2.

Immunology today·2014
Same author

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.

Vox sanguinis·2007
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Carbamazepine, used for epilepsy and nerve pain, can cause rare but severe liver damage. Monitoring liver function is recommended for all patients taking this medication.

Area of Science:

  • Pharmacology
  • Hepatology
  • Neurology

Background:

  • Carbamazepine is a first-line antiepileptic drug also used for trigeminal neuralgia.
  • Common adverse effects include leukopenia and skin rash.
  • Serious hepatic toxicity is a rare but significant concern.

Observation:

  • A case report details a 72-year-old female patient who developed toxic hepatitis.
  • The patient was receiving carbamazepine for a neurological condition.
  • The hepatic injury was attributed to carbamazepine treatment.

Findings:

  • Carbamazepine-induced toxic hepatitis can occur even with standard therapeutic doses.
  • Prompt recognition and discontinuation of the drug are crucial for managing this adverse event.
  • Liver function test abnormalities indicate potential hepatotoxicity.

Related Experiment Videos

Implications:

  • Healthcare providers should consider carbamazepine as a potential cause of hepatitis in patients presenting with liver enzyme elevation.
  • Regular monitoring of liver function tests is advisable for all patients undergoing carbamazepine therapy.
  • This case underscores the importance of pharmacovigilance for antiepileptic drugs.